Olov Aspevall

854 total citations
19 papers, 481 citations indexed

About

Olov Aspevall is a scholar working on Epidemiology, Clinical Biochemistry and Infectious Diseases. According to data from OpenAlex, Olov Aspevall has authored 19 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 6 papers in Clinical Biochemistry and 5 papers in Infectious Diseases. Recurrent topics in Olov Aspevall's work include Pneumonia and Respiratory Infections (5 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Olov Aspevall is often cited by papers focused on Pneumonia and Respiratory Infections (5 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Olov Aspevall collaborates with scholars based in Sweden, Italy and United States. Olov Aspevall's co-authors include Hans O. Hallander, Timo Kouri, Vanya Gant, Mats Erntell, Håkan Hanberger, Sonja Löfmark, Christina Åhrén, Karin Tegmark Wisell, Sigvard Mölstad and Jenny Hellman and has published in prestigious journals such as PLoS ONE, Emerging infectious diseases and Clinical Microbiology and Infection.

In The Last Decade

Olov Aspevall

18 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olov Aspevall Sweden 10 220 147 135 88 79 19 481
Kenneth Iregbu Nigeria 14 277 1.3× 128 0.9× 131 1.0× 84 1.0× 101 1.3× 46 579
Anis Karuniawati Indonesia 15 149 0.7× 177 1.2× 205 1.5× 78 0.9× 58 0.7× 57 520
Laura Folgori Italy 16 290 1.3× 108 0.7× 187 1.4× 111 1.3× 68 0.9× 36 688
Myrto Eleni Flokas United States 13 235 1.1× 119 0.8× 209 1.5× 147 1.7× 123 1.6× 20 605
Ícaro Boszczowski Brazil 14 112 0.5× 160 1.1× 199 1.5× 84 1.0× 48 0.6× 40 550
Johan Struwe Sweden 12 178 0.8× 198 1.3× 163 1.2× 161 1.8× 72 0.9× 29 503
Monica V. Mahoney United States 14 272 1.2× 150 1.0× 187 1.4× 157 1.8× 83 1.1× 43 590
S. Maugat France 12 239 1.1× 79 0.5× 117 0.9× 166 1.9× 89 1.1× 26 488
D. Offra Duerink Netherlands 11 111 0.5× 181 1.2× 136 1.0× 150 1.7× 65 0.8× 15 460
Mark Supino United States 6 180 0.8× 234 1.6× 163 1.2× 90 1.0× 95 1.2× 11 660

Countries citing papers authored by Olov Aspevall

Since Specialization
Citations

This map shows the geographic impact of Olov Aspevall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olov Aspevall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olov Aspevall more than expected).

Fields of papers citing papers by Olov Aspevall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olov Aspevall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olov Aspevall. The network helps show where Olov Aspevall may publish in the future.

Co-authorship network of co-authors of Olov Aspevall

This figure shows the co-authorship network connecting the top 25 collaborators of Olov Aspevall. A scholar is included among the top collaborators of Olov Aspevall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olov Aspevall. Olov Aspevall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hellmark, Bengt, et al.. (2023). [Five cases of C. canimorsus during a short period of time at Östersund Hospital, Sweden].. PubMed. 120.
2.
Rooden, Stephanie M. van, Olov Aspevall, Elena Carrara, et al.. (2021). Governance aspects of large-scale implementation of automated surveillance of healthcare-associated infections. Clinical Microbiology and Infection. 27. S20–S28. 7 indexed citations
3.
Torén, Kjell, Paul D. Blanc, Ingemar Qvarfordt, Olov Aspevall, & Linus Schiöler. (2020). Inhaled Corticosteroids Use and Risk of Invasive Pneumococcal Disease in a Population-based Study. Annals of the American Thoracic Society. 17(12). 1570–1575. 6 indexed citations
4.
Torén, Kjell, Paul D. Blanc, Rajen N. Naidoo, et al.. (2019). Occupational exposure to dust and to fumes, work as a welder and invasive pneumococcal disease risk. Occupational and Environmental Medicine. 77(2). 57–63. 27 indexed citations
5.
Torén, Kjell, Paul D. Blanc, Rajen N. Naidoo, et al.. (2019). Occupational Exposure to Dust and to Fumes, Work As a Welder and Invasive Pneumococcal Disease Risk. SSRN Electronic Journal. 2 indexed citations
6.
Jönsson, Kerstin, Christian G. Giske, Aina Iversen, et al.. (2018). Neonatal intestinal colonization with extended-spectrum β-lactamase–producing Enterobacteriaceae—a 5-year follow-up study. Clinical Microbiology and Infection. 24(9). 1004–1009. 19 indexed citations
7.
Norén, Torbjörn, et al.. (2018). National Surveillance forClostridioides difficileInfection, Sweden, 2009–2016. Emerging infectious diseases. 24(9). 1617–1625. 17 indexed citations
8.
Mölstad, Sigvard, Sonja Löfmark, Mats Erntell, et al.. (2017). Lessons learnt during 20 years of the Swedish strategic programme against antibiotic resistance. Bulletin of the World Health Organization. 95(11). 764–773. 132 indexed citations
9.
Aspevall, Olov, et al.. (2017). 2017 SWEDRES|SVARM. Consumption of antibiotics and occurrence of antibiotic resistance in Sweden.. 8 indexed citations
10.
Desta, Kassu, Yimtubezinash Woldeamanuel, Aklilu Azazh, et al.. (2016). High Gastrointestinal Colonization Rate with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Hospitalized Patients: Emergence of Carbapenemase-Producing K. pneumoniae in Ethiopia. PLoS ONE. 11(8). e0161685–e0161685. 70 indexed citations
11.
12.
Höjgård, Sören, Olov Aspevall, Björn Bengtsson, et al.. (2015). Preventing Introduction of Livestock Associated MRSA in a Pig Population – Benefits, Costs, and Knowledge Gaps from the Swedish Perspective. PLoS ONE. 10(4). e0122875–e0122875. 11 indexed citations
13.
Jónsson, Baldvin, Olov Aspevall, Aina Iversen, et al.. (2011). Long-Term Follow-Up after Neonatal Colonization with Extended Spectrum Beta-Lactamase Gram-Negative Bacteria. Pediatric Research. 70. 457–457. 2 indexed citations
14.
Ransjö, Ulrika, Birgitta Lytsy, Åsa Melhus, et al.. (2010). Hospital outbreak control requires joint efforts from hospital management, microbiology and infection control. Journal of Hospital Infection. 76(1). 26–31. 19 indexed citations
15.
Söderblom, Tomas, Olov Aspevall, Mats Erntell, et al.. (2010). Alarming spread of vancomycin resistant enterococci in Sweden since 2007. Eurosurveillance. 15(29). 34 indexed citations
16.
Aspevall, Olov, Hans O. Hallander, Vanya Gant, & Timo Kouri. (2001). European guidelines for urinalysis: a collaborative document produced by European clinical microbiologists and clinical chemists under ECLM in collaboration with ESCMID. Clinical Microbiology and Infection. 7(4). 173–178. 109 indexed citations
17.
Aspevall, Olov, et al.. (2000). Evaluation of two methods for improving quality of diagnosis of bacteriuria by culture in primary healthcare. Scandinavian Journal of Clinical and Laboratory Investigation. 60(5). 387–394. 4 indexed citations
18.
Aspevall, Olov, et al.. (2000). Performance of Uricult Trio assessed by a comparison method and external control panels in primary healthcare. Scandinavian Journal of Clinical and Laboratory Investigation. 60(5). 381–386. 10 indexed citations
19.
Bengtsson, Stellan, Olov Aspevall, Hans O. Hallander, et al.. (1992). [A proposal for new values in significant bacteriuria].. PubMed. 89(46). 3939–40. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth Iregbu Breakdown of academic impact, for papers by Anis Karuniawati Breakdown of academic impact, for papers by Laura Folgori Breakdown of academic impact, for papers by Myrto Eleni Flokas Breakdown of academic impact, for papers by Ícaro Boszczowski Breakdown of academic impact, for papers by Johan Struwe Breakdown of academic impact, for papers by Monica V. Mahoney Breakdown of academic impact, for papers by S. Maugat Breakdown of academic impact, for papers by D. Offra Duerink Breakdown of academic impact, for papers by Mark Supino
Rankless by CCL
2026